Thursday, August 21, 2014

Cellectar Biosciences Reports Second Quarter 2014 Financial Results …

Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical stage biopharmaceutical company developing innovative agents for the detection and treatment of cancer, is providing an overview of its development programs and financial results for the second quarter 2014. More …

Thursday, August 21, 2014

Gene Technique Identifies Hidden Causes of Brain Malformation

Howard Hughes Medical Institute (HHMI) scientists have developed a strategy for finding disease-causing mutations that lurk in only a small fraction of the body's cells. Such mutations can cause significant problems, but cannot be detected with traditional methods of genetic testing, as well as newer, more costly genome sequencing technologies. More …